Market Overview

Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

Share:
Related PFE
How To Approach Q4 Earnings: The Global Perspective
How 7 New Laws Affected Stocks In The Last Week
Related LLY
40 Stocks Moving In Friday's Pre-Market Session
The Daily Biotech Pulse: Regulatory Roadblock For Immunomedics, AdCom Split On Lexicon's Diabetes Drug
Realty Income: Halftime Report (Seeking Alpha)

Deutsche Bank's Gregory Gilbert initiated coverage on some of the largest Big Pharma stocks Wednesday morning.

  • Pfizer (NYSE: PFE) - Buy rating and $34 price target - Shares up 0.9 percent to $29.48.
  • Eli Lilly (NYSE: LLY) - Buy and $71 target - Stock up 0.25 percent to $62.97.
  • Merck (NYSE: MRK) - Hold and $63 target - Stock up 0.4 percent to $60.41.
  • Bristol-Myers Squibb (NYSE: BMY) - Hold and $52 target - Shares trading down one percent to $50.25 at last check.

(Click the company's name to see the full-length report.)

The entire healthcare sector, according to the iShares DJ US Healthcare ETF (NYSE: IYH), is up about 0.1 percent. The S&P 500 is currently trading down less than a point to 1,999.43.

Latest Ratings for PFE

DateFirmActionFromTo
Dec 2018JP MorganDowngradesOverweightNeutral
Nov 2018CitigroupMaintainsSellSell
Nov 2018BMO CapitalDowngradesOutperformMarket Perform

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: News Price Target Initiation Analyst Ratings

 

Related Articles (IYH + BMY)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
MDRXKeyBancUpgrades0.0
ANETNomuraUpgrades260.0
CNPRBC CapitalUpgrades34.0
FISVOppenheimerUpgrades88.0
FNDUBSUpgrades37.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Best Buy: Problems And Potential

Isis Pharmaceuticals Finally Breaks Out